Jürgen Engel
Keine laufenden Positionen mehr
Profil
Dr. Jürgen Engel is President & Chief Executive Officer at AEterna Zentaris, Inc. He is on the Board of Directors at Isotechnika Pharma, Inc.
Dr. Engel was previously employed as Chief Executive Officer by Zentaris GmbH.
He received his undergraduate degree from the University of Regensburg and a doctorate degree from the Technical University of Braunschweig.
Ehemalige bekannte Positionen von Jürgen Engel
| Unternehmen | Position | Ende |
|---|---|---|
| AETERNA ZENTARIS INC. | Präsident | 15.04.2013 |
Isotechnika Pharma, Inc.
 Isotechnika Pharma, Inc. Pharmaceuticals: MajorHealth Technology Isotechnika Pharma, Inc. is a biopharmaceutical company, which focuses on discovery and development of immunomodulating therapeutics. Its products include voclosporin and non-immunosuppressive cyclosporine analogue molecules. The company was founded by Robert T. Foster founded on June 16, 1993 and is headquartered in Edmonton, Canada. | Direktor/Vorstandsmitglied | 18.02.2011 |
AEterna Zentaris GmbH
 AEterna Zentaris GmbH Miscellaneous Commercial ServicesCommercial Services AEterna Zentaris GmbH engages in biopharmaceutical research. It specializes in the fields of oncology and endocrinology. The company is headquartered in Frankfurt, Germany. | Vorstandsvorsitzender | - |
| Zentaris GmbH | Präsident | - |
Ausbildung von Jürgen Engel
| University of Regensburg | Undergraduate Degree |
| Technische Universität Braunschweig | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| AETERNA ZENTARIS INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
| Zentaris GmbH | |
Isotechnika Pharma, Inc.
Isotechnika Pharma, Inc. Pharmaceuticals: MajorHealth Technology Isotechnika Pharma, Inc. is a biopharmaceutical company, which focuses on discovery and development of immunomodulating therapeutics. Its products include voclosporin and non-immunosuppressive cyclosporine analogue molecules. The company was founded by Robert T. Foster founded on June 16, 1993 and is headquartered in Edmonton, Canada. | Health Technology |
AEterna Zentaris GmbH
AEterna Zentaris GmbH Miscellaneous Commercial ServicesCommercial Services AEterna Zentaris GmbH engages in biopharmaceutical research. It specializes in the fields of oncology and endocrinology. The company is headquartered in Frankfurt, Germany. | Commercial Services |
